Long COVID Supplements: What the Human Trials Actually Show
Long COVID is not a small tail of the pandemic. A meta-analysis of 50 studies put the pooled prevalence of post-COVID condition at 0.43, with fatigue the most common symptom at 23% [1]. Cumulative global incidence is estimated at around 400 million people, at an annual economic cost close to $1 trillion [2]. If you are still exhausted months after the infection cleared, your symptoms are real and you are not alone.
Most guides to long COVID supplements give you a list and no numbers. This one grades every nutrient by the human evidence, names the dose and sample size, and reports the failed trials. These are supplements for long COVID, and they are adjuncts, not a cure.
What Long COVID Is, and Why Fatigue Happens
Long COVID, also called post-COVID condition, is the name for symptoms that persist or appear after the acute infection and do not settle. Mechanisms under study include viral persistence, immune dysregulation, mitochondrial dysfunction, endothelial inflammation, and microbiome dysbiosis [2][38].
In skeletal muscle, researchers find impaired mitochondrial function, endothelial abnormalities, and a shift toward glycolytic fibers, all of which contribute to reduced exercise capacity [25][26].

That helps explain why exercise feels disproportionately hard. Brain fog sits in the same picture, and our guide to brain and memory support covers the cognitive side.
Post-exertional malaise needs its own warning. A case-control study found measurable muscle damage and amyloid-containing deposits that worsened after exertion [24]. Pushing through PEM is not a training problem. It is a signal to pace. The mitochondrial dysfunction guide explains the energy system.
The Short Answer: Which Supplements Have Real Trial Evidence

Two major evidence syntheses set the bar. A 2024 BMJ living systematic review of 24 trials and 3,695 patients found moderate certainty evidence for online cognitive behavioral therapy and supervised combined physical and mental health rehabilitation. It found no compelling evidence for any supplement it assessed, including combined probiotics and prebiotics, coenzyme Q10, and L-arginine plus vitamin C [3]. A 2026 European Respiratory Journal guideline conditionally recommends multispecies probiotics, CBT for fatigue, and personalized rehabilitation after post-exertional malaise is ruled out [4].
That does not mean nothing works. It means the evidence is early. Here is the short version.
| Nutrient or intervention | Best human evidence | Dose used | Verdict |
|---|---|---|---|
| L-arginine plus vitamin C | Single-blind RCT, 50 people | 1.66 g plus 500 mg liposomal vitamin C, twice daily, 28 days | Strongest signal (grade B) |
| Creatine | RCT, 67 people | 6 g daily plus exercise, 4 weeks | Modest and consistent (grade B) |
| CoQ10 plus alpha-lipoic acid | Observational, 174 people | 100 mg plus 100 mg, twice daily, 2 months | Encouraging, not randomized (grade C) |
| CoQ10 alone | RCT, 119 people | 500 mg daily, 6 weeks per period | Negative (grade D) |
| Vitamin D | RCT, 80 people | 60,000 IU weekly, 8 weeks | Improved fatigue in one trial (grade B) |
| PEA plus luteolin | RCT, 39 people | 700 mg plus 70 mg, twice daily, 8 weeks | Mechanistic signal only (grade B) |
| Multispecies synbiotic | RCT, 26 people | 3 months, multi-strain with FOS and zinc | Small PEM signal (grade B) |
| Lactoferrin | RCT, 72 people | 1,200 mg daily, 6 weeks | Negative (grade D) |
| Beetroot juice | RCT, 31 people | About 600 mg nitrate daily, 14 days | Negative for function (grade D) |
| NAC | Retrospective series, 9 patients (3 took NAC) | 600 to 1,200 mg twice daily | Too weak to grade (grade C) |
Grade B means one small randomized trial, C means observational data, and D means a randomized trial found no benefit.
L-Arginine Plus Vitamin C: The Strongest Single Trial
The strongest result for any single supplement in long COVID comes from a single-blind randomized trial of 50 people, 46 of whom completed it [5]. The 2024 BMJ review did not find the evidence for this combination compelling [3], so treat it as a signal rather than a settled finding. Participants took 1.66 g of L-arginine plus 500 mg of liposomal vitamin C twice daily for 28 days.
- Six-minute walk distance rose 30 m versus 0 m (p=0.001).
- Handgrip rose 3.4 kg versus 1 kg (p=0.03).
- Flow-mediated dilation, a measure of endothelial function, was 14.3% with L-arginine plus vitamin C versus 9.4% with placebo (p=0.03).
- Fatigue was still reported by 8.7% of the treated group versus 80.1% of controls (p<0.0001).
L-arginine is a nitric oxide precursor, which is why the trial measured endothelial function [5]. Our heart and circulation resources explain why oxygen delivery matters.
Caveats: single-blind, one center, small. L-arginine can lower blood pressure, so check with your clinician if you take blood pressure medication.
Creatine: Small Trials, Consistent Signal
Creatine has two randomized trials in long COVID, both small. In the larger, 67 people were randomized and 58 completed four weeks of 6 g or 18 g daily plus exercise three times weekly [6]. The 6 g arm cut Piper Fatigue Score by 2.05 points and raised handgrip by 4.4 kgf.
The second was a three-arm trial of 15 people, and its 8 g creatine plus 3 g glucose arm took that dose daily for 8 weeks [7]. They reported less body ache, better concentration, fewer headaches, easier breathing, and less malaise. Brain creatine rose too.
Tissue creatine is lower in long COVID muscle and brain than reference values [33]. One caveat: both trials are too small to settle it. Agape Nutrition's creatine listings are currently out of stock, so treat this as information, not a recommendation. For the overlapping fatigue literature, see supplements for chronic fatigue.
CoQ10 and Alpha-Lipoic Acid: More Mixed Than the Blogs Say
A prospective observational study of 174 people compared 116 who took 100 mg CoQ10 plus 100 mg alpha-lipoic acid twice daily for two months with 58 who did not [8]. Complete response on the Fatigue Severity Scale was 53.5% versus 3.5%.
Impressive, but it was neither randomized nor placebo-controlled. People who seek treatment often improve for other reasons.
The randomized evidence points the other way at a higher dose. A double-blind crossover trial gave 500 mg of CoQ10 daily for six weeks per period to 119 completers and found no significant difference in symptom score or quality of life [9].
So CoQ10 plus alpha-lipoic acid is a reasonable option to discuss, but it is not established. In ME/CFS, CoQ10 plus NADH reduced cognitive fatigue within the treated group [20], and a review of 14 studies found weak signals with high risk of bias [30].
Vitamin D: Test First, Then Dose
Vitamin D is the clearest case for testing before buying. A double-blind trial gave 80 people 60,000 IU weekly for 8 weeks [10]. Chalder Fatigue fell 3.5 points, anxiety 2.0, and cognitive scores improved 2.1. Sleep, depression, IL-6, and CRP did not change.
That result came from people with long COVID, not a proxy group. But a 2024 meta-analysis of 37 articles found the evidence for vitamin D in preventing long COVID conflicting, with no conclusion possible for multivitamins, vitamin A, or B vitamins in COVID-19 management [39].
Sequence matters: test 25(OH)D, correct a documented deficiency, then retest. High-dose protocols need monitoring because vitamin D raises calcium, and hypercalcemia is not benign. Combined magnesium and vitamin D deficiency has been linked to more clinical manifestations [29].
Probiotics and the Gut Axis
The 2026 ERJ guideline conditionally supports multispecies probiotics for long COVID [4], and reviews describe microbiome dysbiosis as part of the mechanism [2][37].
- A three-month multispecies synbiotic with FOS and zinc improved post-exertional malaise in 26 people (interaction p=0.02) [13].
- A psychobiotic of Lactobacillus helveticus and Bifidobacterium longum at 3 billion CFU for 6 weeks cut anxiety 57.2% and depression 50.9% in the 56 people analyzed, from 62 randomized [14].
- A multistrain synbiotic for 35 days preserved microbial diversity and prevented falls in lymphocytes and hemoglobin in 52 people [15].
- A five-strain probiotic at 5 billion CFU for 28 days shortened fatigue and anxiety after COVID in 73 people [16].
Strain and product matter, so one formulation's result does not transfer to another bottle. Our digestion and gut health resources cover strain selection.
PEA Plus Luteolin: Promising but Tiny
Palmitoylethanolamide, or PEA, is an endocannabinoid-like compound studied for neuroinflammation. A double-blind trial of 39 people used 700 mg of PEA plus 70 mg of luteolin twice daily for 8 weeks [11].
The outcome was mechanistic: the combination restored GABA-B-ergic activity and cortical plasticity on transcranial magnetic stimulation. That is a real physiological finding, but not a symptom score, and 39 people is a pilot. An observational comparison of 98 people found 600 mg of PEA twice daily for three months improved depression and fatigue more than no treatment [12]. The trial product was co-ultramicronized, and absorption differs, so a generic capsule is not interchangeable.
What the Evidence Does Not Support
Several popular recommendations failed in trials or rest on thin data.
- Lactoferrin. In 72 people, 1,200 mg daily for 6 weeks did not improve fatigue or any secondary outcome compared with placebo, although fatigue fell in both arms [17].
- Beetroot juice. About 600 mg of nitrate daily for 14 days in 31 randomized people (25 completers) did not improve fatigue resistance, walk distance, handgrip, or flow-mediated dilation compared with placebo, though gut microbiota and inflammatory markers shifted [18].
- Multiple micronutrients for prevention. Given for 14 days from the first sign of symptoms in 246 people, they did not reduce post-COVID condition at 180 days (27.7% with the supplement versus 25.0% with placebo) [19].
- NAC. The enthusiasm rests on a retrospective series of 9 patients, 3 of whom took 600 to 1,200 mg twice daily and reported subjective improvement [23]. That is a hypothesis, not proof.
- NAD and NMN. A review of 10 trials and 489 participants found NAD precursors well tolerated, with some fatigue signals in chronic fatigue and side effects including muscle pain, sleep disturbance, and headache [21]. The quoted NMN trial used 250 mg daily in 108 older adults, not people with long COVID [22]. Our NAD supplement guide covers what the data supports.
- Sulforaphane and curcumin. We found no human long COVID trial for either. The signals come from cells and animals.
- Pycnogenol. Open-label data in 60 people look promising [31], but the randomized trial is only at protocol stage [32].
What to Test Before You Buy Anything

Symptoms overlap with several treatable deficiencies, and guessing wastes months. Ask for:
- CBC, to rule out anemia.
- Ferritin and iron saturation. One cross-sectional study of post-COVID patients with musculoskeletal symptoms found iron deficiency in 39.7% [28], and impaired red cell function with lower plasma iron has been documented [27].
- B12 and folate, ideally with methylmalonic acid and homocysteine. Symptoms overlap with B12 deficiency, and one-carbon metabolism is disrupted after COVID [34][35].
- 25(OH)D, to dose vitamin D properly [10].
- Magnesium, especially if vitamin D is low [29].
- TSH, HbA1c, and CRP, for thyroid, blood sugar, and inflammation.
- Sleep apnea screening, because unrefreshing sleep has its own cause.
- Orthostatic vitals if you feel dizzy on standing. Our POTS supplements guide explains the overlap.
Safety: Pacing, Interactions, and What Not to Combine
- Do not push through post-exertional malaise. Muscle damage worsens after exertion, and immune infiltration is part of the picture [24][25]. Treat PEM as a ceiling, not a hurdle.
- Watch bleeding risk. Nattokinase, bromelain, high-dose omega-3, vitamin E, and NAC can add to anticoagulant or antiplatelet effects. Tell your clinician what you take, and stop before surgery.
- Kidney disease. Creatine and magnesium need medical sign-off if kidney function is reduced.
- Vitamin D and K2. Monitor calcium with high-dose protocols. Vitamin K2 can reduce the effect of warfarin and other vitamin K antagonists, so check before combining.
- Pregnancy and breastfeeding. Ask before starting anything, including gentle nutrients.
- Histamine intolerance and MCAS. Some probiotic strains worsen flushing, headache, or gut symptoms. Start low, one product at a time.
- Trial one thing at a time for 4 to 8 weeks, with a simple symptom log. Stacking five products tells you nothing.
What We Recommend
These three correspond to the three areas discussed above: mitochondrial support, a multispecies probiotic, and the vitamin D step that follows a low test.
Researched Nutritionals ATP Fuel 150 Capsules
supports normal mitochondrial energy production, with stabilized NADH and CoQ10 built into the formula.
$71.98
Researched Nutritionals Multi-Biome 30 Capsules
is a six-strain spore and live-strain blend, in the multispecies category the guideline cited above conditionally supports [4], though that support does not extend to any specific product.
$51.98
XYMOGEN K2-D3 5000, 120 Capsules
provides 5,000 IU of D3 with K2, at a daily dose rather than the weekly 60,000 IU trial protocol, and only after a test shows a need.
$64.99
Frequently Asked Questions
What is the best supplement for long COVID fatigue?
On current evidence, L-arginine plus vitamin C has the strongest single trial [5], with creatine second [6]. Both are small, and neither is a cure.
Do long COVID vitamins actually work?
Some do, at specific doses. Vitamin D helped fatigue at 60,000 IU weekly [10], while a multiple micronutrient product did not prevent post-COVID condition [19].
How long should I try a supplement before deciding?
Give it 4 to 8 weeks, one product at a time, and log fatigue, sleep, brain fog, and side effects. If nothing changes, stop.
Can supplements fix long COVID mitochondrial dysfunction?
Mitochondrial dysfunction is documented in long COVID [26], and several nutrients support energy metabolism [36]. None has been shown to reverse it.
Is creatine safe if I have long COVID?
Trials used 6 g daily for 4 weeks and 8 g daily for 8 weeks. The 4-week trial reported only minimal, transient adverse events [6]. Kidney disease needs clinician sign-off.
Does NAC help long COVID brain fog?
The only human report is a retrospective series of 9 gynecologic cancer patients, 3 of whom took NAC [23]. That is not enough to recommend it.
What about NAD IVs or NMN?
NAD precursors have been studied mostly in chronic fatigue and older adults, not long COVID [21][22]. IV therapy is unstudied.
When should I see a doctor instead of self-treating?
If symptoms persist or worsen, or you have chest pain, breathlessness at rest, fainting, or new neurological symptoms, get medical review.
References
- Chen C, Haupert SR, Zimmermann L, Shi X, Fritsche LG, Mukherjee B. Global Prevalence of Post-Coronavirus Disease 2019 (COVID-19) Condition or Long COVID: A Meta-Analysis and Systematic Review. J Infect Dis. 2022. PMID 35429399. https://pubmed.ncbi.nlm.nih.gov/35429399/
- Al-Aly Z, Davis H, McCorkell L, Soares L, Wulf-Hanson S, Iwasaki A, Topol EJ. Long COVID science, research and policy. Nat Med. 2024. PMID 39122965. https://pubmed.ncbi.nlm.nih.gov/39122965/
- Zeraatkar D, Ling M, Kirsh S, et al. Interventions for the management of long covid (post-covid condition): living systematic review. BMJ. 2024. PMID 39603702. https://pubmed.ncbi.nlm.nih.gov/39603702/
- Cao B, Soriano JB, Wang Q, et al. Clinical practice guideline for long COVID prevention and treatment. Eur Respir J. 2026. PMID 41856572. https://pubmed.ncbi.nlm.nih.gov/41856572/
- Tosato M, Calvani R, Picca A, et al. Effects of l-Arginine Plus Vitamin C Supplementation on Physical Performance, Endothelial Function, and Persistent Fatigue in Adults with Long COVID: A Single-Blind Randomized Controlled Trial. Nutrients. 2022. PMID 36501014. https://pubmed.ncbi.nlm.nih.gov/36501014/
- Dos Santos MSC, Dorna MS, Costa AF, et al. Creatine supplementation on fatigue related to post-COVID-19 condition: a randomized controlled trial. Front Nutr. 2026. PMID 41958909. https://pubmed.ncbi.nlm.nih.gov/41958909/
- Slankamenac J, Ranisavljev M, Todorovic N, et al. Eight-Week Creatine-Glucose Supplementation Alleviates Clinical Features of Long COVID. J Nutr Sci Vitaminol (Tokyo). 2024. PMID 38684388. https://pubmed.ncbi.nlm.nih.gov/38684388/
- Barletta MA, Marino G, Spagnolo B, et al. Coenzyme Q10 + alpha lipoic acid for chronic COVID syndrome. Clin Exp Med. 2023. PMID 35994177. https://pubmed.ncbi.nlm.nih.gov/35994177/
- Hansen KS, Mogensen TH, Agergaard J, et al. High-dose coenzyme Q10 therapy versus placebo in patients with post COVID-19 condition: a randomized, phase 2, crossover trial. Lancet Reg Health Eur. 2023. PMID 36337437. https://pubmed.ncbi.nlm.nih.gov/36337437/
- Charoenporn V, Tungsukruthai P, Teacharushatakit P, et al. Effects of an 8-week high-dose vitamin D supplementation on fatigue and neuropsychiatric manifestations in post-COVID syndrome: A randomized controlled trial. Psychiatry Clin Neurosci. 2024. PMID 39072958. https://pubmed.ncbi.nlm.nih.gov/39072958/
- Versace V, Ortelli P, Dezi S, et al. Co-ultramicronized palmitoylethanolamide/luteolin normalizes GABAB-ergic activity and cortical plasticity in long COVID-19 syndrome. Clin Neurophysiol. 2023. PMID 36455453. https://pubmed.ncbi.nlm.nih.gov/36455453/
- Merolla A, De Lorenzo R, Paolazzi G, et al. Micronized/ultramicronized palmitoylethanolamide improves depression and fatigue in coronavirus disease 2019 (COVID-19) survivors. Int Clin Psychopharmacol. 2024. PMID 38381905. https://pubmed.ncbi.nlm.nih.gov/38381905/
- Ranisavljev M, Stajer V, Todorovic N, et al. The effects of 3-month supplementation with synbiotic on patient-reported outcomes, exercise tolerance, and brain and muscle metabolism in adult patients with post-COVID-19 chronic fatigue syndrome (STOP-FATIGUE): a randomized placebo-controlled clinical trial. Eur J Nutr. 2024. PMID 39592468. https://pubmed.ncbi.nlm.nih.gov/39592468/
- Drzymała S, Blask-Osipa A, Szczepańska-Álvarez A, et al. The Impact of Psychobiotic Therapy on Anxiety and Depressive Symptoms in Patients with Post-COVID Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial. Metabolites. 2026. PMID 42646330. https://pubmed.ncbi.nlm.nih.gov/42646330/
- Giancola ML, Fontana A, Panebianco C, et al. Efficacy of a Multistrain Synbiotic Treatment in Acute and Post-Acute COVID-19 Patients: A Double-Blind, Placebo-Controlled Randomized Trial. Microorganisms. 2024. PMID 39065211. https://pubmed.ncbi.nlm.nih.gov/39065211/
- Kolesnyk PO, Paliy IH, Sydorchuk LP, et al. The role of nutritional support with probiotics in outpatients with symptomatic acute respiratory tract infections: a multicenter, randomized, double-blind, placebo-controlled dietary study. BMC Nutr. 2024. PMID 38178223. https://pubmed.ncbi.nlm.nih.gov/38178223/
- Redel AL, Miry F, Hellemons ME, Oswald LMA, Braunstahl GJ. Effect of lactoferrin treatment on symptoms and physical performance in long COVID patients: a randomised, double-blind, placebo-controlled trial. ERJ Open Res. 2024. PMID 39076533. https://pubmed.ncbi.nlm.nih.gov/39076533/
- Calvani R, Giampaoli O, Marini F, et al. Beetroot juice intake positively influenced gut microbiota and inflammation but failed to improve functional outcomes in adults with long COVID: A pilot randomized controlled trial. Clin Nutr. 2024. PMID 39571342. https://pubmed.ncbi.nlm.nih.gov/39571342/
- Tomasa-Irriguible TM, Monfà R, Miranda-Jiménez C, et al. Preventive Intake of a Multiple Micronutrient Supplement during Mild, Acute SARS-CoV-2 Infection to Reduce the Post-Acute COVID-19 Condition: A Double-Blind, Placebo-Controlled, Randomized Clinical Trial. Nutrients. 2024. PMID 38892564. https://pubmed.ncbi.nlm.nih.gov/38892564/
- Castro-Marrero J, Segundo MJ, Lacasa M, et al. Effect of Dietary Coenzyme Q10 Plus NADH Supplementation on Fatigue Perception and Health-Related Quality of Life in Individuals with Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: A Prospective, Randomized, Double-Blind, Placebo-Controlled Trial. Nutrients. 2021. PMID 34444817. https://pubmed.ncbi.nlm.nih.gov/34444817/
- Gindri IM, Ferrari G, Pinto LPS, et al. Evaluation of safety and effectiveness of NAD in different clinical conditions: a systematic review. Am J Physiol Endocrinol Metab. 2024. PMID 37971292. https://pubmed.ncbi.nlm.nih.gov/37971292/
- Kim M, Seol J, Sato T, et al. Effect of 12-Week Intake of Nicotinamide Mononucleotide on Sleep Quality, Fatigue, and Physical Performance in Older Japanese Adults: A Randomized, Double-Blind Placebo-Controlled Study. Nutrients. 2022. PMID 35215405. https://pubmed.ncbi.nlm.nih.gov/35215405/
- Bellone S, Siegel ER, Santin AD. N-acetylcysteine (NAC) supplementation improves dyspnea and may normalize von Willebrand plasma levels in gynecologic patients with Post-Acute-COVID-Sequela (PASC)/Long COVID. Gynecol Oncol Rep. 2025. PMID 39944180. https://pubmed.ncbi.nlm.nih.gov/39944180/
- Appelman B, Charlton BT, Goulding RP, et al. Muscle abnormalities worsen after post-exertional malaise in long COVID. Nat Commun. 2024. PMID 38177128. https://pubmed.ncbi.nlm.nih.gov/38177128/
- Charlton BT, Goulding RP, Jaspers RT, et al. Skeletal muscle adaptations and post-exertional malaise in long COVID. Trends Endocrinol Metab. 2025. PMID 39694730. https://pubmed.ncbi.nlm.nih.gov/39694730/
- Molnar T, Lehoczki A, Fekete M, et al. Mitochondrial dysfunction in long COVID: mechanisms, consequences, and potential therapeutic approaches. GeroScience. 2024. PMID 38668888. https://pubmed.ncbi.nlm.nih.gov/38668888/
- Kronstein-Wiedemann R, Tausche K, Kolditz M, et al. Long-COVID is Associated with Impaired Red Blood Cell Function. Horm Metab Res. 2024. PMID 37890507. https://pubmed.ncbi.nlm.nih.gov/37890507/
- Garre S, Krishna Prasad CR, Pratyusha AC, et al. Assessment of micronutrient levels in patients with post COVID musculoskeletal manifestations: A cross-sectional observational study. J Family Med Prim Care. 2025. PMID 41041185. https://pubmed.ncbi.nlm.nih.gov/41041185/
- Wolf FI, Trapani V. Magnesium and vitamin D in long COVID syndrome; do they help? Magnes Res. 2024. PMID 38652733. https://pubmed.ncbi.nlm.nih.gov/38652733/
- Dorczok MC, Mittmann G, Mossaheb N, et al. Dietary Supplementation for Fatigue Symptoms in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): A Systematic Review. Nutrients. 2025. PMID 39940333. https://pubmed.ncbi.nlm.nih.gov/39940333/
- Belcaro G, Cornelli U, Cesarone MR, et al. Preventive effects of Pycnogenol on cardiovascular risk factors (including endothelial function) and microcirculation in subjects recovering from coronavirus disease 2019 (COVID-19). Minerva Med. 2022. PMID 34060731. https://pubmed.ncbi.nlm.nih.gov/34060731/
- Radtke T, Künzi L, Kopp J, et al. Effects of Pycnogenol in people with post-COVID-19 condition (PYCNOVID): study protocol for a single-center, placebo controlled, quadruple-blind, randomized trial. Trials. 2024. PMID 38879571. https://pubmed.ncbi.nlm.nih.gov/38879571/
- Ranisavljev M, Todorovic N, Ostojic J, Ostojic SM. Reduced tissue creatine levels in patients with long COVID-19: A cross-sectional study. J Postgrad Med. 2023. PMID 37171415. https://pubmed.ncbi.nlm.nih.gov/37171415/
- McCaddon A, Regland B. COVID-19: A methyl-group assault? Med Hypotheses. 2021. PMID 33657459. https://pubmed.ncbi.nlm.nih.gov/33657459/
- Perła-Kaján J, Jakubowski H. COVID-19 and One-Carbon Metabolism. Int J Mol Sci. 2022. PMID 35456998. https://pubmed.ncbi.nlm.nih.gov/35456998/
- Chen LZ, Cai Q, Zheng PF. Mitochondrial metabolic rescue in post-COVID-19 syndrome: MR spectroscopy insights and precision nutritional therapeutics. Front Immunol. 2025. PMID 40486513. https://pubmed.ncbi.nlm.nih.gov/40486513/
- Lau RI, Su Q, Ng SC. Long COVID and gut microbiome: insights into pathogenesis and therapeutics. Gut Microbes. 2025. PMID 39854158. https://pubmed.ncbi.nlm.nih.gov/39854158/
- Gupta G, Buonsenso D, Wood J, et al. Mechanistic Insights Into Long Covid: Viral Persistence, Immune Dysregulation, and Multi-Organ Dysfunction. Compr Physiol. 2025. PMID 40474772. https://pubmed.ncbi.nlm.nih.gov/40474772/
- Sinopoli A, Sciurti A, Isonne C, et al. The Efficacy of Multivitamin, Vitamin A, Vitamin B, Vitamin C, and Vitamin D Supplements in the Prevention and Management of COVID-19 and Long-COVID: An Updated Systematic Review and Meta-Analysis of Randomized Clinical Trials. Nutrients. 2024. PMID 38732592. https://pubmed.ncbi.nlm.nih.gov/38732592/
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
